Company: HVIIR
Filing Date: 2025-12-23
Form Type: S-4
Source: 0001493152-25-029121
Chunk: 370

Company: Hennessy Capital Investment Corp. VII
Filing Date: 2025-12-23
Form: S-4
Chunk 370
---
 Nuclear and interest in the transaction; |

| ● | the                                                                                       
 material facts of the proposed transaction, including the proposed aggregate value of the 
 transaction;                                                                              |

| ● | the                                                                                            
 impact on a director’s or a director nominee’s independence in the event the                   
 related person is a director or director nominee or an immediate family member of the director 
 or director nominee;                                                                           |

| ● | the                                                      
 benefits to New ONE Nuclear of the proposed transaction; |

| ● | if                                                                                    
 applicable, the availability of other sources of comparable products or services; and |

| ● | an                                                                                          
 assessment of whether the proposed transaction is on terms that are comparable to the terms 
 available to an unrelated third party or to employees generally.                            |

If advance audit committee approval of a related person transaction requiring the audit committee’s approval is not feasible, then the transaction may be preliminarily entered into by management upon prior approval of the transaction by the chair of the audit committee, subject to ratification of the transaction by the audit committee at the audit committee’s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. If a transaction was not initially recognized as a related person transaction, then, upon such recognition, the transaction will be presented to the audit committee for ratification at the audit committee’s next regularly scheduled meeting; provided, that if ratification is not forthcoming, management will make all reasonable efforts to cancel or annul the transaction. New ONE Nuclear’s management will update the audit committee as to any material changes to any approved or ratified related person transaction and will provide a status report at least annually of all then current related person transactions. No director will be permitted to participate in the approval of a related person transaction for which he or she is a related person.

In addition, under New ONE Nuclear’s code of business conduct and ethics, which will be adopted effective upon the consummation of the Transaction, New ONE Nuclear’s employees, directors and director nominees will have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest.

| 241 |

<div align='center'>DESCRIPTION OF NEW ONE NUCLEAR SECURITIES</div>

The following description summarizes the most important terms of the New ONE Nuclear securities, as expected to be in effect upon the consummation of the Transaction. We expect to adopt the New ONE Nuclear Charter and the New ONE Nuclear Bylaws in connection with the Closing, and this